Clinical Trial Update: Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing continuous subcutaneous insulin infusion of faster-acting insulin aspart with NovoRapid in adults with type 1 diabetes; completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Faster-acting insulin aspart (insulin aspart)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2018-07-24